Scheen A J
Département de Médecine, Université de Liège.
Rev Med Liege. 1998 Aug;53(8):459-66.
The most important drugs registered and/or launched in Belgium during the last year in the various disciplines of internal medicine will be briefly described. The originality of each molecule as well as its modalities of appropriate use in clinical practice will be stressed. This first part is devoted to drugs acting on cardiovascular, respiratory, digestive and neurologic diseases.
